The worst drug rule revisited: mathematical modeling of cyclic cancer treatments
DOI10.1007/S11538-010-9539-YzbMATH Open1226.92037OpenAlexW2075672121WikidataQ46592038 ScholiaQ46592038MaRDI QIDQ644401FDOQ644401
Allen A. Katouli, Natalia L. Komarova
Publication date: 4 November 2011
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s11538-010-9539-y
Recommendations
- scientific article; zbMATH DE number 1114142
- scientific article; zbMATH DE number 1343152
- Mathematical modeling of cyclic treatments of chronic myeloid leukemia
- Drug resistance in cancer chemotherapy as an optimal control problem
- Optimal therapy scheduling based on a pair of collaterally sensitive drugs
Medical applications (general) (92C50) Applications of branching processes (60J85) Miscellaneous topics in calculus of variations and optimal control (49N99)
Cites Work
- The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics
- ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES
- Title not available (Why is that?)
- Cancer Modelling and Simulation
- Handbook of stochastic methods for physics, chemistry and the natural sciences.
- A model for the resistance of tumor cells to cancer chemotherapeutic agents
- A stochastic model for the origin and treatment of tumors containing drug-resistant cells
- Title not available (Why is that?)
- The fixed-size Luria-Delbrück model with a nonzero death rate
- A branching-process model for heterogeneous cell populations
- Selected topics in cancer modeling. Genesis, evolution, immune competition, and therapy
Cited In (6)
- The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling
- On probabilistic certification of combined cancer therapies using strongly uncertain models
- Optimal therapy scheduling based on a pair of collaterally sensitive drugs
- Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model
- Modeling the role of altruism of antibiotic-resistant bacteria
- A branching process model of heterogeneous DNA damages caused by radiotherapy in \textit{in vitro} cell cultures
This page was built for publication: The worst drug rule revisited: mathematical modeling of cyclic cancer treatments
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q644401)
